126 results
8-K
EX-99.1
GLYC
GlycoMimetics Inc
27 Mar 24
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023
9:00am
, regulatory interactions, or submissions; the company’s collaborations with third parties; and the potential benefits and impact of the company’s drug
PRE 14A
GLYC
GlycoMimetics Inc
22 Mar 24
Preliminary proxy
5:00pm
service through the applicable vesting date.
Pension Benefits and Nonqualified Deferred Compensation
Our named executive officers did not participate … in, or otherwise receive any benefits under, any pension plan or nonqualified deferred compensation plan sponsored by us during 2023.
Employment
8-K
EX-99.1
jhtr3hf4hlqe4pg
1 Mar 24
Regulation FD Disclosure
9:16am
8-K
EX-99.1
uppsnk7jrwr8f
3 Nov 23
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023
8:35am
8-K
EX-99.1
5fz6k
2 Aug 23
GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2023
8:35am
8-K
EX-99.1
v8v03w
3 May 23
GlycoMimetics Reports Highlights and Financial Results for First Quarter 2023
8:36am